Biogen Bolsters Neurology Pipeline with C4 Therapeutics and Skyhawk Deals
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 1 (Table of Contents)
Published: 22 Jan-2019
DOI: 10.3833/pdr.v2019.i1.2397 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Biogen has entered into deals with two privately-owned companies, C4 Therapeutics (C4T) and Skyhawk Therapeutics, to bolster its early-stage neurology pipeline...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS